Company: INDP
Filing Date: 2025-01-14
Form Type: 8-K
Source: 0001493152-25-002145
Chunk: 5

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-01-14
Form: 8-K
Item: Item 9.01
Chunk 5
---
Item       Financial                 

(d)
Exhibits.

  Exhibit      Description                                                                                                                                                                                           
      No.                                                                                                                                                                                                            
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
     10.1      Form of Securities Purchase Agreement                                                                                                                                                                 
     10.2      Form of Warrant                                                                                                                                                                                       
     10.3      Form of Placement Agent Warrant                                                                                                                                                                       
     10.4      Placement Agent Agreement, dated as of December 12, 2024, by and between Indaptus Therapeutics, Inc. and Paulson Investment Company, LLC as amended by the First Amendment to the Placement Agent...  
     99.1      Press Release of the Company dated January 13, 2025                                                                                                                                                   
      104      Cover                                                                                                                                                                                                 

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

Date:
January 14, 2025